LOADING
Comparing NVIDIA Corporation (NVDA) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $305.1B |
| P/E Ratio | -- | 34.8 |
| Forward P/E | -- | 24.4 |
| PEG Ratio | -- | 6.10 |
| EPS | -- | $3.55 |
| Revenue Growth (YoY) | -- | 4.9% |
| Profit Margin | -- | 13.6% |
| Return on Equity | -- | 18.9% |
| Dividend Yield | -- | 2.62% |
| Beta | -- | 0.20 |
| 52-Week High | -- | $130.29 |
| 52-Week Low | -- | $74.18 |
| Volume | -- | -- |